Potential benefit of hormonal therapy for non-uterine soft tissue sarcoma (STS) – a case report and literature review

The expression of hormone receptors (HR) is considered a good prognostic marker in uterine sarcoma. Hormonal therapy is widely employed in the therapy of HR positive breast and gynecologic cancers, however, there is little information concerning hormonal therapy in HR positive extrauterine sarcoma....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Schuster, Isaiah P, Jacob, Robin, Hupart, Kenneth H, Gotlieb, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825229/
https://www.ncbi.nlm.nih.gov/pubmed/24255838
http://dx.doi.org/10.1186/2193-1801-2-536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825229/
https://www.ncbi.nlm.nih.gov/pubmed/24255838
http://dx.doi.org/10.1186/2193-1801-2-536

Ejemplares similares